AMNEAL PHARMACEUTICALS INC (AMRX) Forecast, Price Target & Analyst Ratings

NASDAQ:AMRX • US03168L1052

Current stock price

12.235 USD
+0.29 (+2.47%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMNEAL PHARMACEUTICALS INC (AMRX).

Forecast Snapshot

Consensus Price Target

Price Target
$14.79
+ 20.88% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
$0.17
Revenue Estimate
727.81M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.82%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.79
Upside
+ 20.88%
From current price of $12.24 to mean target of $14.79, Based on 11 analyst forecasts
Low
$13.13
Median
$15.30
High
$15.75

Price Target Revisions

1 Month
0.00%
3 Months
8.75%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for AMRX. The average price target is 14.79 USD. This implies a price increase of 20.88% is expected in the next year compared to the current price of 12.235.
The average price target has been revised upward by 8.75% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AMRX Current Analyst RatingAMRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

AMRX Historical Analyst RatingsAMRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
81.82%
AMRX was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AMRX.
In the previous month the buy percentage consensus was at a similar level.
AMRX was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-02Truist SecuritiesMaintains Buy -> Buy
2025-12-09BarclaysInitiate Overweight
2025-10-31Piper SandlerReiterate Overweight -> Overweight
2025-09-16JP MorganMaintains Overweight -> Overweight
2025-03-03BarclaysMaintains Overweight -> Overweight
2025-02-24JP MorganUpgrade Neutral -> Overweight
2024-11-11Piper SandlerMaintains Overweight -> Overweight
2024-10-02Truist SecuritiesMaintains Buy -> Buy
2024-09-06JP MorganUpgrade Underweight -> Neutral
2024-08-13BarclaysMaintains Overweight -> Overweight
2024-08-12Truist SecuritiesMaintains Buy -> Buy
2024-05-06Truist SecuritiesReiterate Buy -> Buy
2024-05-06Goldman SachsMaintains Buy -> Buy
2024-03-21Piper SandlerMaintains Overweight -> Overweight
2024-03-04Goldman SachsMaintains Buy -> Buy
2024-01-29BarclaysMaintains Overweight -> Overweight
2023-11-08Truist SecuritiesMaintains Buy -> Buy
2023-09-06Truist SecuritiesReiterate Buy -> Buy
2023-08-07BarclaysMaintains Overweight -> Overweight
2023-08-07Truist SecuritiesMaintains Buy -> Buy
2023-08-07Piper SandlerMaintains Overweight -> Overweight
2023-05-08Piper SandlerMaintains Overweight
2023-03-29Truist SecuritiesMaintains Buy
2023-03-10BarclaysMaintains Overweight
2023-03-03BMO CapitalMaintains Market Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
$0.17
Revenue Estimate
727.81M
Revenue Q2Q
4.66%
EPS Q2Q
-21.07%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
-3.71%
Revenue (3 Months)
-3.81%
EPS (1 Month)
-16.34%
EPS (3 Months)
-15.95%

Next Earnings Summary

AMRX is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is 0.17 USD and the consensus revenue estimate is 727.81M USD.
The next earnings revenue estimate has been revised downward by 3.81% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
AMRX revenue by date.AMRX revenue by date.
2.394B
8.20%		2.794B
16.73%		3.019B
8.05%		3.186B
5.54%		3.403B
6.81%		3.575B
5.05%		2.912B
-18.55%		3.002B
3.09%
EBITDA
YoY % growth
AMRX ebitda by date.AMRX ebitda by date.
504.247M
14.74%		584.564M
15.93%		621.486M
6.32%		751.85M
20.98%		836.89M
11.31%		919.97M
9.93%		738.68M
-19.71%		773.36M
4.69%
EBIT
YoY % growth
AMRX ebit by date.AMRX ebit by date.
274.847M
37.90%		348.373M
26.75%		397.914M
14.22%		681.37M
71.24%		769M
12.86%		850.97M
10.66%		444.01M
-47.82%		455.02M
2.48%
Operating Margin
AMRX operating margin by date.AMRX operating margin by date.
11.48%12.47%13.18%21.39%22.60%23.80%15.25%15.16%
EPS
YoY % growth
AMRX eps by date.AMRX eps by date.
0.64
-5.88%		0.58
-9.37%		0.84
44.83%		0.98
16.11%		1.18
20.90%		1.37
15.78%		1.02
-25.28%		1.11
9.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.17
-21.07%		0.23
-7.14%		0.27
56.90%		0.30
41.18%		0.26
53.85%		0.28
20.83%		0.33
22.37%		0.35
18.69%
Revenue
Q2Q % growth		727.81M
4.66%		777.12M
7.26%		839.07M
6.95%		858.77M
5.46%		770.61M
5.88%		795.91M
2.42%		861.9M
2.72%		895.25M
4.25%
EBITDA
Q2Q % growth		149.91M
-6.93%		177.81M
-23.45%		189.97M
-22.41%		205.54M
-39.20%		N/AN/AN/AN/A
EBIT
Q2Q % growth		132.03M
30.83%		148.43M
32.52%		164.65M
133.59%		170.65M
49.04%		171.77M
30.10%		176.87M
19.16%		203.18M
23.40%		216.55M
26.90%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AMRX Yearly Revenue VS EstimatesAMRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
AMRX Yearly EPS VS EstimatesAMRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.57%
EPS Next 5 Year
5.77%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
5.18%
Revenue Next 5 Year
-0.46%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
13.50%
EBIT Next 5 Year
4.21%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AMNEAL PHARMACEUTICALS INC / AMRX Forecast FAQ

What is the price target for AMRX stock?

11 analysts have analysed AMRX and the average price target is 14.79 USD. This implies a price increase of 20.88% is expected in the next year compared to the current price of 12.235.

What is the next earnings date for AMRX stock?

AMNEAL PHARMACEUTICALS INC (AMRX) will report earnings on 2026-04-30.

What are the consensus estimates for AMNEAL PHARMACEUTICALS INC (AMRX) next earnings?

The consensus EPS estimate for the next earnings of AMNEAL PHARMACEUTICALS INC (AMRX) is 0.17 USD and the consensus revenue estimate is 727.81M USD.

What is the consensus rating for AMRX stock?

The consensus rating for AMNEAL PHARMACEUTICALS INC (AMRX) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.